The predictive value of respiratory function tests for non-invasive ventilation in amyotrophic lateral sclerosis

Respir Res. 2017 Jul 25;18(1):144. doi: 10.1186/s12931-017-0624-8.

Abstract

Background: Non-invasive ventilation (NIV) improves survival and quality of life in amyotrophic lateral sclerosis (ALS) patients. The timing of referral to a home ventilation service (HVS), which is in part based on respiratory function tests, has shown room for improvement. It is currently unknown which respiratory function test predicts an appropriate timing of the initiation of NIV.

Methods: We analysed, retrospectively, serial data of five respiratory function tests: forced vital capacity (FVC), peak cough flow (PCF), maximum inspiratory and expiratory pressure (MIP and MEP) and sniff nasal inspiratory pressure (SNIP) in patients with ALS. Patients who had had at least one assessment of respiratory function and one visit at the HVS, were included. Our aim was to detect the test with the highest predictive value for the need for elective NIV in the following 3 months. We analysed time curves, currently used cut-off values for referral, and respiratory function test results between 'NIV indication' and 'no-NIV indication' patients.

Results: One hundred ten patients with ALS were included of whom 87 received an NIV indication; 11.5% had one assessment before receiving an NIV indication, 88.5% had two or more assessments. The NIV indication was based on complaints of hypoventilation and/or proven (nocturnal) hypercapnia. The five respiratory function tests showed a descending trend during disease progression, where SNIP showed the greatest decline within the latest 3 months before NIV indication (mean = -22%). PCF at the time of referral to the HVS significantly discriminated between the groups 'NIV-indication' and 'no NIV-indication yet' patients at the first HVS visit: 259 (±92) vs. 348 (±137) L/min, p = 0.019. PCF and SNIP showed the best predictive characteristics in terms of sensitivity.

Conclusion: SNIP showed the greatest decline prior to NIV indication and PCF significantly differentiated 'NIV-indication' from 'no NIV-indication yet' patients with ALS. Currently used cut-off values might be adjusted and other respiratory function tests such as SNIP and PCF may become part of routine care in patients with ALS in order to avoid non-timely initiation of (non-invasive) ventilation.

Keywords: ALS; Non-invasive ventilation; Respiratory function tests.

MeSH terms

  • Aged
  • Amyotrophic Lateral Sclerosis / diagnosis*
  • Amyotrophic Lateral Sclerosis / physiopathology
  • Amyotrophic Lateral Sclerosis / therapy*
  • Area Under Curve
  • Clinical Decision-Making
  • Cough / physiopathology
  • Disease Progression
  • Female
  • Humans
  • Lung / physiopathology*
  • Male
  • Maximal Respiratory Pressures
  • Middle Aged
  • Muscle Strength
  • Noninvasive Ventilation*
  • Patient Selection
  • Predictive Value of Tests
  • ROC Curve
  • Reproducibility of Results
  • Respiratory Function Tests / methods*
  • Respiratory Muscles / physiopathology*
  • Retrospective Studies
  • Time Factors
  • Time-to-Treatment
  • Vital Capacity